Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

October 1, 2024; Volume 65,Issue 10

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 6A;

Editor’s Page

  • You have access
    Is ChatGPT a Reliable Ghostwriter?
    Irène Buvat and Wolfgang A. Weber
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 1499-1502; DOI: https://doi.org/10.2967/jnumed.124.268341

Commentary

  • You have access
    Navigating the Future of Prostate Cancer Care: AI-Driven Imaging and Theranostics Through the Lens of RELAINCE
    Aaron Jun Ning Wong, Hyun Soo Ko and Michael S. Hofman
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 1503-1504; DOI: https://doi.org/10.2967/jnumed.124.267924

The State of the Art

  • The Rise of Molecular Image–Guided Robotic Surgery
    You have access
    The Rise of Molecular Image–Guided Robotic Surgery
    Fijs W.B. van Leeuwen, Tessa Buckle, Matthias N. van Oosterom and Daphne D.D. Rietbergen
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 1505-1511; DOI: https://doi.org/10.2967/jnumed.124.267783

Focus on Molecular Imaging

  • You have access
    Nuclear Imaging of Bispecific Antibodies on the Rise
    Borna Roohani, Aldred Shane Mendez, Mann Dangarwala, Samantha Katz and Bernadette Marquez-Nostra
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 1512-1517; DOI: https://doi.org/10.2967/jnumed.123.267215

Is It Really Happening?

  • You have access
    1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?
    Uwe Haberkorn, Annette Altmann, Frederik L. Giesel and Clemens Kratochwil
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 1518-1520; DOI: https://doi.org/10.2967/jnumed.124.267923

Oncology

  • Clinical

    • Association Between CA 15-3 and <sup>18</sup>F-FDG PET/CT Findings in Recurrent Breast Cancer Patients at a Tertiary Referral Hospital in Kenya
      You have access
      Association Between CA 15-3 and 18F-FDG PET/CT Findings in Recurrent Breast Cancer Patients at a Tertiary Referral Hospital in Kenya
      Margaret M. Mwania, Samuel Nguku Gitau, Jasmit Shah and Khalid Makhdomi
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1521-1525; DOI: https://doi.org/10.2967/jnumed.124.267851
    • Development of <sup>18</sup>F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance
      You have access
      Development of 18F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance
      Rick Wray, Audrey Mauguen, Laure Michaud, Doris Leithner, Randy Yeh, Nadeem Riaz, Rosna Mirtcheva, Eric Sherman, Richard Wong, John Humm, Nancy Lee and Heiko Schöder
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1526-1532; DOI: https://doi.org/10.2967/jnumed.124.267775
    • Diagnostic Accuracy of [<sup>18</sup>F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Metaanalysis
      You have access
      Diagnostic Accuracy of [18F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Metaanalysis
      Akram Al-Ibraheem, Ahmed Abdlkadir, Ken Herrmann, Jamshed Bomanji, Hossein Jadvar, Hongcheng Shi, Asem Mansour, Diana Paez, Arturo Chiti and Andrew M. Scott
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1533-1539; DOI: https://doi.org/10.2967/jnumed.124.268049
    • Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer
      You have access
      Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer
      Bertha Eisses, Jasper J.L. van Geel, Adrienne H. Brouwers, Frederike Bensch, Sjoerd G. Elias, Evelien J.M. Kuip, Agnes Jager, Bert van der Vegt, Marjolijn N. Lub-de Hooge, Jasper Emmering, Anne I.J. Arens, Gerben J.C. Zwezerijnen, Daniëlle J. Vugts, C. Willemien Menke-van der Houven van Oordt, Elisabeth G.E. de Vries and Carolina P. Schröder
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1540-1547; DOI: https://doi.org/10.2967/jnumed.124.267636
    • Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer with [<sup>68</sup>Ga]Ga-FAPI-04 PET, [<sup>18</sup>F]FDG PET, and Contrast-Enhanced MRI: Lesion-to-Lesion Comparison with Pathology
      You have access
      Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer with [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI: Lesion-to-Lesion Comparison with Pathology
      Xiao Zhang, Zhenyu Lin, Yuan Feng, Zhaoguo Lin, Kaixiong Tao, Tao Zhang and Xiaoli Lan
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1548-1556; DOI: https://doi.org/10.2967/jnumed.124.267581
    • Evaluating the Utility of <sup>18</sup>F-FDG PET/CT in Cancer of Unknown Primary
      You have access
      Evaluating the Utility of 18F-FDG PET/CT in Cancer of Unknown Primary
      Tharani Sivakumaran, Anthony Cardin, Jason Callahan, Hui-li Wong, Richard W. Tothill, Rodney J. Hicks and Linda R. Mileshkin
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1557-1563; DOI: https://doi.org/10.2967/jnumed.123.267274
  • Basic

    • Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting
      Open Access
      Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting
      Sophie Poty, Laura Ordas, Yana Dekempeneer, Ali Asghar Parach, Laurent Navarro, Francis Santens, Nina Dumauthioz, Manuel Bardiès, Tony Lahoutte, Matthias D’Huyvetter and Jean-Pierre Pouget
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1564-1570; DOI: https://doi.org/10.2967/jnumed.124.267624

Theranostics

  • Clinical

    • Clinical Factors That Influence Repeat <sup>68</sup>Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative <sup>68</sup>Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study
      You have access
      Clinical Factors That Influence Repeat 68Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative 68Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study
      Pan Thin, Masatoshi Hotta, Andrei Gafita, Tristan Grogan, Johannes Czernin, Jeremie Calais and Ida Sonni
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1571-1576; DOI: https://doi.org/10.2967/jnumed.124.267591
    • Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [<sup>18</sup>F]PSMA-1007 PET/CT
      Open Access
      Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [18F]PSMA-1007 PET/CT
      Matteo Bauckneht, Francesca D’Amico, Domenico Albano, Michele Balma, Camilla Cabrini, Francesco Dondi, Tania Di Raimondo, Virginia Liberini, Luca Sofia, Simona Peano, Mattia Riondato, Giuseppe Fornarini, Riccardo Laudicella, Luca Carmisciano, Egesta Lopci, Roberta Zanca, Marcello Rodari, Stefano Raffa, Maria Isabella Donegani, Daniela Dubois, Leonardo Peñuela, Cecilia Marini, Francesco Bertagna, Alberto Papaleo, Silvia Morbelli, Gianmario Sambuceti, Marta Ponzano and Alessio Signori
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1577-1583; DOI: https://doi.org/10.2967/jnumed.124.267751
    • Quantitative SPECT/CT Metrics in Early Prediction of [<sup>177</sup>Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients
      You have access
      Quantitative SPECT/CT Metrics in Early Prediction of [177Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients
      Onur Tuncer, Daniel Steinberger, Joseph Steiner, Madeleine Hinojos, Stephanie Y. Rhee, Brad Humphrey, Farhad Jafari and Zuzan Cayci
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1584-1590; DOI: https://doi.org/10.2967/jnumed.124.267964
    • Dual Somatostatin Receptor/<sup>18</sup>F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors
      You have access
      Dual Somatostatin Receptor/18F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors
      Ur Metser, Jose E. Nunez, David Chan, Roshini Kulanthaivelu, Vanessa Murad, Anna T. Santiago and Simron Singh
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1591-1596; DOI: https://doi.org/10.2967/jnumed.124.267982
    • FEATURED ARTICLE OF THE MONTH

      • [<sup>68</sup>Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series
        You have access
        [68Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series
        Alex J. Poot, Constantin Lapa, Wolfgang A. Weber, Marnix G.E.H. Lam, Matthias Eiber, Alexander Dierks, Ralph A. Bundschuh and Arthur J.A.T. Braat
        Journal of Nuclear Medicine October 1, 2024, 65 (10) 1597-1603; DOI: https://doi.org/10.2967/jnumed.124.268147
  • Basic

    • Preclinical Evaluation of <sup>177</sup>Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors
      You have access
      Preclinical Evaluation of 177Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors
      Andrea Galbiati, Matilde Bocci, Domenico Ravazza, Jacqueline Mock, Ettore Gilardoni, Dario Neri and Samuele Cazzamalli
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1604-1610; DOI: https://doi.org/10.2967/jnumed.124.268200
    • Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled Radiohapten
      You have access
      Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent 177Lu-Labeled Radiohapten
      Brett A. Vaughn, Sang-gyu Lee, Daniela Burnes Vargas, Shin Seo, Sara S. Rinne, Hong Xu, Hong-fen Guo, Alexandre B. Le Roux, Leah Gajecki, Simone Krebs, Guangbin Yang, Ouathek Ouerfelli, Pat B. Zanzonico, Edward K. Fung, Samantha St. Jean, Sebastian E. Carrasco, Achim Jungbluth, Nai Kong V. Cheung, Steven M. Larson, Darren R. Veach and Sarah M. Cheal
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1611-1618; DOI: https://doi.org/10.2967/jnumed.124.267685
    • FEATURED BASIC SCIENCE ARTICLE

      • The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for <sup>161</sup>Tb Compared with <sup>177</sup>Lu with a Higher Dose Response for [<sup>161</sup>Tb]Tb-DOTA-LM3 Than for [<sup>161</sup>Tb]Tb-DOTATATE
        You have access
        The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for 161Tb Compared with 177Lu with a Higher Dose Response for [161Tb]Tb-DOTA-LM3 Than for [161Tb]Tb-DOTATATE
        Kaat Spoormans, Lara Struelens, Koen Vermeulen, Marijke De Saint-Hubert, Michel Koole and Melissa Crabbé
        Journal of Nuclear Medicine October 1, 2024, 65 (10) 1619-1625; DOI: https://doi.org/10.2967/jnumed.124.267873
    • Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECT
      Open Access
      Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECT
      Hudson Alakonya, Sofia Koustoulidou, Samantha L. Hopkins, Mathew Veal, Javier Ajenjo, Deborah Sneddon, Gemma Dias, Michael Mosley, Julia Baguña Torres, Francesca Amoroso, Amanda Anderson, Alison H. Banham and Bart Cornelissen
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1626-1632; DOI: https://doi.org/10.2967/jnumed.124.267736

Cardiovascular

  • Basic

    • Design, Synthesis, and Preclinical Evaluation of a High-Affinity <sup>18</sup>F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction
      You have access
      Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction
      Rebecca Sullivan, Jinqiang Hou, Lihai Yu, Benjamin Wilk, Jane Sykes, Heather Biernaski, John Butler, Michael Kovacs, Justin Hicks, Jonathan D. Thiessen, Rohan Dharmakumar, Frank S. Prato, Gerald Wisenberg, Leonard G. Luyt and Savita Dhanvantari
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1633-1639; DOI: https://doi.org/10.2967/jnumed.124.267578

Endocrinology

  • Clinical

    • BRIEF COMMUNICATION

      • C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
        You have access
        C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
        Johanna S. Enke, Kathrin Ritzel, Evelyn Asbach, Nic G. Reitsam, Bruno Märkl, Thomas Knösel, Denise Brüdgam, Malte Kircher, Christian H. Pfob, Ralph A. Bundschuh, Andreas Rinscheid, Bernd Nittbaur, Georgine Wienand, Margret Schottelius, Martin Reincke, Constantin Lapa and Alexander Dierks
        Journal of Nuclear Medicine October 1, 2024, 65 (10) 1640-1644; DOI: https://doi.org/10.2967/jnumed.124.268169

Neurology

  • Clinical

    • Improving <sup>18</sup>F-FDG PET Quantification Through a Spatial Normalization Method
      Open Access
      Improving 18F-FDG PET Quantification Through a Spatial Normalization Method
      Daewoon Kim, Seung Kwan Kang, Seong A. Shin, Hongyoon Choi and Jae Sung Lee
      Journal of Nuclear Medicine October 1, 2024, 65 (10) 1645-1651; DOI: https://doi.org/10.2967/jnumed.123.267360

AI/Advanced Image Analysis

  • Ultrashort Oncologic Whole-Body [<sup>18</sup>F]FDG Patlak Imaging Using LAFOV PET
    You have access
    Ultrashort Oncologic Whole-Body [18F]FDG Patlak Imaging Using LAFOV PET
    Joyce van Sluis, Johannes H. van Snick, Andor W.J.M. Glaudemans, Riemer H.J.A. Slart, Walter Noordzij, Adrienne H. Brouwers, Rudi A.J.O. Dierckx, Adriaan A. Lammertsma, Charalampos Tsoumpas and Ronald Boellaard
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 1652-1657; DOI: https://doi.org/10.2967/jnumed.124.267784

The Illustrated Post

  • You have access
    [68Ga]Ga-PSMA-11 PET/CT–Positive Hepatic Inflammatory Pseudotumor: Possible PSMA-Avid Pitfall in Nuclear Imaging
    Fabio Monastero, Luigia Vetrone, Lina Cardisciani, Matteo Renzulli, Enrico Prosperi, Matteo Cescon, Matteo Ravaioli, Stefano Fanti, Andrea Farolfi and Francesco Vasuri
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 1658-1659; DOI: https://doi.org/10.2967/jnumed.124.267518

Departments

  • You have access
    Erratum
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 1651;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 65 (10)
Journal of Nuclear Medicine
Vol. 65, Issue 10
October 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • [68Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series
  • The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for 161Tb Compared with 177Lu with a Higher Dose Response for [161Tb]Tb-DOTA-LM3 Than for [161Tb]Tb-DOTATATE
Sign up for alerts

Jump to

  • This Month in JNM
  • Editor’s Page
  • Commentary
  • The State of the Art
  • Focus on Molecular Imaging
  • Is It Really Happening?
  • Oncology
    • Clinical
    • Basic
  • Theranostics
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Cardiovascular
    • Basic
  • Endocrinology
    • Clinical
      • BRIEF COMMUNICATION
  • Neurology
    • Clinical
  • AI/Advanced Image Analysis
  • The Illustrated Post
  • Departments
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire